![Page 1: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/1.jpg)
INSIGHTS INTO HIV CARE SERVICE
COMPREHENSIVENESS AND
LABORATORY CAPACITY AT ICAP-SUPPORTED FACILITIES:
FINDINGS FROM PFACTS 2013Caitlin Madevu-Matson ([email protected])
Charon Gwynn ([email protected])SI-NY
![Page 2: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/2.jpg)
PFACTS• Structured repeated assessment of facilities to
describe the scope, diversity, capacity and comprehensiveness of ICAP-supported programs
• Captures information not available from routine indicators :
– Context: Location, type
– Facility characteristics: Related services, e.g. ANC, MC
– Clinic and lab components: Staffing configuration and training, patient support services, laboratory quality essentials
• Data used for program planning, monitoring and evaluation
– Reports and webinars
– URS
– Analyses with other data sources
![Page 3: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/3.jpg)
PFACTS IMPLEMENTATION
• Assessment tools– Core questions maintained from previous
round, tool revised with clinical and programs units
• Data collection– Assessments completed with health facility
personnel– Questionnaires reviewed by in-country ICAP
clinical and M&E units• Data validated through checks and results
uploaded to URS
Care and Treatment PFaCTS
• 7 rounds, 2007 - 2013
• 80 questions
Laboratory PFaCTS• 2 rounds, 2011 -
2013• 162 questions
![Page 4: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/4.jpg)
CARE & TREATMENT PFACTS
Objectives• Present results
from Care and treatment PFaCTS Round 7
• Describe the comprehensiveness of ICAP-supported programs
![Page 5: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/5.jpg)
OUTLINE
• PFaCTS implementation
• Current characteristics
– Context
– Facility
– Clinic
• Comprehensiveness of HIV Care Service
• Summary
• Implications
![Page 6: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/6.jpg)
DEFINITIONS
Facility
Clinic
![Page 7: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/7.jpg)
COMPLETENESS OF PFACTS REPORTING OVER TIME
Round 1 (2007)
Round 2 (2007)
Round 3 (2008)
Round 4 (2009)
Round 5 (2010)
Round 6 (2011)
Round 7 (2013)
-
200
400
600
800
1,000
1,200
211 227
356
541
687
1,003 1,062
158 202
345
490
665
977 1,017
Facilities supported Facilities assessed
Num
ber o
f fac
ilitie
s
![Page 8: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/8.jpg)
COMPLETENESS OF PFACTS REPORTING OVER TIME
Round 1 (2007)
Round 2 (2007)
Round 3 (2008)
Round 4 (2009)
Round 5 (2010)
Round 6 (2011)
Round 7 (2013)
-
200
400
600
800
1,000
1,200
211 227
356
541
687
1,003 1,062
158 202
345
490
665
977 1,017
Facilities supported Facilities assessed
Num
ber o
f fac
ilitie
s
75%
96%
![Page 9: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/9.jpg)
OUTLINE
• PFaCTS implementation
• Current characteristics– Context : country, location and type
– Facility : services provided outside the CT clinic
– Clinic : services provided in the CT clinic
• Comprehensiveness of HIV Care Service
• Summary
• Implications
![Page 10: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/10.jpg)
COUNTRIES CONTRIBUTING TO PFACTS ROUND 7
• 96% (1017/1062) of facilities with ICAP-supported care and treatment services completed PFaCTS Round 7
• In country completeness ranged from 79% to 100%
Cote d'Ivoire n=27 DR Congo
n=50
Ethiopia n=312
Kenya n=260
Mozambique
n=77
Swaziland
n=83
Tanzania
n=208
![Page 11: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/11.jpg)
FACILITY LOCATION AND TYPE
Geographic location Type of facility0
20
40
60
80
100
Urban; 16.71583088
Semi-urban; 32.74336283
Rural; 50.54080629
Public primary; 64
Public secondary / ter-tiary; 15
Private/other; 21
Perc
ent o
f fac
ilitie
s, %
![Page 12: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/12.jpg)
AVAILABILITY OF HIV RELATED SERVICES (n=1017)
PITC in any clinic/ward PMTCT in ANC TB treatment0
20
40
60
80
100100 97
88
Perc
ent o
f fac
ilitie
s, %
![Page 13: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/13.jpg)
PMTCT SERVICE VARIATION (N=991)
ART in ANC WHO Option0
20
40
60
80
100
ART in ANC; 64.48
Refer to HIV clinic; 32.8
Refer to other facility, 2.72
Option A; 66
Option B; 3
Option B+; 30
Perc
ent o
f fac
ilitie
s, %
![Page 14: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/14.jpg)
TB SERVICE VARIATION (N=1,017)
IPT Triage of TB suspects TB treatment0
20
40
60
80
100
58.6
72
TB clinic only; 60.18
HIV care clinic only; 20.94
HIV care and TB clinic; 6.59
Perc
ent o
f fac
ilitie
s, %
![Page 15: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/15.jpg)
AVAILABILITY OF KEY PATIENT SUPPORT SERVICES (n=1017)
ART adherence
couns
eling
Male co
ndom provis
ion
Outreach
Nutritiona
l treatm
ent (ch
ildren)
Nutritiona
l treatm
ent (ad
ults)0
20
40
60
80
100 99
8881 79
74
Perc
ent o
f fac
ilitie
s, %
![Page 16: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/16.jpg)
TYPE OF ART ADHERENCE SUPPORT AVAILABLE
Clinic a
ppoin
tmen
t remind
er ca
rds
Hando
uts
Pill box
es or
bliste
r pac
ks
Calend
ars or
chec
klist to
track
ART
Clinic s
creen
s edu
catio
nal vi
deos
0
20
40
60
80
100
82
2824
5 3
Perc
ent o
f fac
ilitie
s, %
![Page 17: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/17.jpg)
OUTREACH ACTIVITIES BY TYPE OF PERSONNEL
Peer educator Clinicians Outreach worker Social worker Other0
20
40
60
80
100
61
42
16
59
Perc
ent o
f fac
ilitie
s, %
![Page 18: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/18.jpg)
SECONDARY PREVENTION SERVICE AVAILABILITY
0
20
40
60
80
100 99
7870
45
Perc
ent o
f fac
ilitie
s, %
![Page 19: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/19.jpg)
OUTLINE
• PFaCTS implementation
• Current characteristics
– Context
– Facility
– Clinic
• Comprehensiveness of HIV Care Service
• Summary
• Implications
![Page 20: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/20.jpg)
HIV CARECOMPREHENSIVENE
SSCOMPONENTSQuestions
• Does ICAP support comprehensive HIV care programs?
• Has comprehensiveness of HIV care programs changed over time?
• Is there variability in the changes?
![Page 21: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/21.jpg)
WHO Priority Interventions
1. Enabling people to know their HIV status
VCT / PITC
2. Maximizing the health sector’s response to HIV prevention
Preventing sexual transmission
Interventions for IDU
PMTCT
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Treatment and care for HIV
Lab services for HIV monitoring
![Page 22: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/22.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV prevention
Preventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TB
Nutritional counseling
Treatment and care for HIV
Adherence support
Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 23: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/23.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV prevention
Preventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TB
Nutritional counseling
Treatment and care for HIV
Adherence support
Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 24: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/24.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV prevention
Preventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TB
Nutritional counseling
Treatment and care for HIV
Adherence support
Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 25: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/25.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV prevention
Preventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TB
Nutritional counseling
Treatment and care for HIV
Adherence support
Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 26: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/26.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV prevention
Preventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TB
Nutritional counseling
Treatment and care for HIV
Adherence support
Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 27: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/27.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV prevention
Preventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TB
Nutritional counseling
Treatment and care for HIV
Adherence support
Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 28: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/28.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV prevention
Preventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TB
Nutritional counseling
Treatment and care for HIV
Adherence support
Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 29: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/29.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV prevention
Preventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TB
Nutritional counseling
Treatment and care for HIV
Adherence support
Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 30: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/30.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV prevention
Preventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TB
Nutritional counseling
Treatment and care for HIV
Adherence support
Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 31: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/31.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV prevention
Preventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TB
Nutritional counseling
Treatment and care for HIV
Adherence support
Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 32: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/32.jpg)
WHO Priority Interventions
Comprehensive components from PFaCTS
1. Enabling people to know their HIV status
VCT / PITC PITC on-site
2. Maximizing the health sector’s response to HIV prevention
Preventing sexual transmission
Education on behavior change, STI screening, condoms
Interventions for IDU Screening and education on substance use
PMTCT PMTCT on-site
3. Scaling up HIV/AIDS treatment and care
Preventing and treating illness
Cotrimoxazole and TB
Nutritional counseling
Treatment and care for HIV
Adherence support
Outreach services
Lab services for HIV monitoring CD4 on- or off-site
![Page 33: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/33.jpg)
COMPREHENSIVE SERVICES OVER TIME
2007 n= 245
2008 n= 345
2009 n= 490
2009 n= 666
2011 n= 977
2013 n= 1017
0
20
40
60
80
100
1624
55
69 73 7353
44
29
23 18 2230 26
148 9 41 5 2 1
High (7) Medium (6) Low (3-5) Very low (<3)
Perc
ent o
f fac
ilitie
s, %
![Page 34: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/34.jpg)
COMPREHENSIVE SERVICES OVER TIME, SUBSET
2007 2008 2009 2010 2011 20130
20
40
60
80
100
16
24
55
6973 73
1518
57
94 92 90
All participating facilities (increasing n) Subset of facilities participating in every round (n=93)
Perc
ent o
f fac
ilitie
s, %
![Page 35: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/35.jpg)
COMPREHENSIVE SERVICES OVER TIME, BY FACILITY TYPE
Public Primary Public Secondary/Tertiary Private/Other0
20
40
60
80
100
2007 2008 2009 2010 2011 2013
Perc
ent o
f fac
ilitie
s, %
![Page 36: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/36.jpg)
OUTLINE
• PFaCTS implementation
• Current characteristics
– Context
– Facility
– Clinic
• Comprehensiveness of HIV Care Service
• Summary
• Implications
![Page 37: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/37.jpg)
CT SUMMARY (1)
• Overall, ICAP facilities maintained high survey completeness
• High on-site availability of essential HIV care services
• Counseling and testing• PMTCT• TB treatment• ART adherence counseling• Outreach • Nutritional counseling• Secondary prevention
![Page 38: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/38.jpg)
CT SUMMARY (2)
• The comprehensiveness of essential HIV care services at all ICAP-supported facilities increased rapidly in 2009 and seems to have stabilized
• Higher proportion of facilities have comprehensive services in
• Facilities supported by ICAP for longer time
• Public primary and secondary/tertiary compared to private/other
![Page 39: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/39.jpg)
• ICAP-supported facilities provide comprehensive services even though most facilities are rural and public primary facilities
• Scale up and expansion of ICAP support to new areas may mean not all facilities will be equipped to offer comprehensive services
• Combine PFaCTS results with routinely collected program and clinical data
– Confirm if availability of comprehensive services is beneficial for program and patient outcomes
– Advocate for wider implementation of comprehensive service delivery models
IMPLICATIONS FOR HIV CARE AND TREATMENT
![Page 40: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/40.jpg)
Laboratory PFaCTS
![Page 41: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/41.jpg)
Outline
• Rationale & Objectives• General findings• Capacity score• Summary& Implications
![Page 42: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/42.jpg)
Laboratory PFaCTS• Captures information on the scope,
diversity, and capacity of ICAP-supported laboratories
• Provides information on laboratory quality essentials (QEs)– Infrastructure and equipment– Human resources– Quality assurance activities– Facility safety– Supply chain management
• Two rounds of PFaCTS conducted to date (2011 & 2013)
![Page 43: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/43.jpg)
RATIONALE FOR LABORATORY PFACTS
• At the facility level:– Measure capacity and progress toward
accreditation– Gap analysis and development of laboratory
specific improvement plan
• At the program level:– Identify gaps in implementing QEs across
supported labs– Prioritization and strategy development
![Page 44: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/44.jpg)
ICAP’S LABORATORY CAPACITY BUILDING FRAMEWORK
Objective Components
1. Improve Integrated Laboratory Infrastructure
physical infrastructure, equipment and accessories
2. Strengthen laboratory personnel capacity
personnel capacity to provide high-quality diagnostic services
3. Improve Laboratory Quality Management System
quality management systems & lab accreditation
4. Strengthen the laboratory network system
laboratory referral system & EQA schemes
![Page 45: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/45.jpg)
OBJECTIVES
• To summarize findings from Lab PFaCTS 2013
• To compare laboratory capacity between years and by key characteristics
![Page 46: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/46.jpg)
OUTLINE
• Rationale & Objectives• General findings• Capacity score• Summary& Implications
![Page 47: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/47.jpg)
PEPFAR DEFINITION OF CLINICAL LABORATORY
Laboratory that has the capacity to: Perform testing for the diagnosis of HIV infection with either rapid test, EIA or molecular methods; and
Has dedicated laboratory personnel
Perform clinical laboratory tests in any of the following areas:Hematology - Clinical chemistry - Serology Microbiology - CD4 testing - HIV viral loads
TB diagnostic - Malaria diagnosis - OI diagnosis
![Page 48: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/48.jpg)
LABORATORIES COMPLETING PFACTS 2013
# Supported # Reported % Reported
Ethiopia 295 289 98
Kenya 184 182 99
Tanzania 175 119 68
Mozambique 58 53 91
Cote d'lvoire 10 4 40
DR Congo 8 7 88
All Countries 730 654 90
![Page 49: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/49.jpg)
ICAP SUPPORTED LABORATORIES BY FACILITY TYPE AND COUNTRY
All countries (n=654)
Kenya (n=182)
Tanzania (n=119)
Ethiopia (n=289)
Mozambique (n=53)
Cote d'Ivoire (n=4)
DR Congo (n=7)
0
20
40
60
80
100
7887
6680 77
14
1913
26
18 21
10086
3 1 8 2 2
Primary Secondary Tertiary/reference lab
Perc
ent o
f lab
orat
orie
s, %
![Page 50: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/50.jpg)
TYPE OF SUPPORT PROVIDED BY ICAP
AccreditationConstruction/revnovation
RefurbishmentSafety supplies
Processing suppliesEquipment maintenance
Human resourcesTest kit/regent supply
EQASample transportation
EquipmentSupervision
Documents developmentTraining & mentoring
0 20 40 60 80 100
9
15
18
22
25
33
36
41
53
62
69
69
80
91
Percent of laboratories, %
![Page 51: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/51.jpg)
TYPE OF HIV-RELATED TESTS PERFORMED ONSITE
HIV rapid test AFB Syphilis Hematology CD4 count Clinic chem-istry
CD4 percent0
20
40
60
80
10097
92
83
48
27 26
9
Perc
ent o
f lab
orat
orie
s, %
![Page 52: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/52.jpg)
Light/Fluore
scence
micro
scope
Refrigera
tor
Back u
p gen
erator
Hemotology analy
zer
Clinica
l chem
istry a
nalyz
er
CD4 mac
hine
0
20
40
60
80
100
88
69
42
28 25 22
ESSENTIAL EQUIPMENT FOR HIV CARE
Perc
ent o
f lab
orat
orie
s, %
![Page 53: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/53.jpg)
TYPE OF BIOSAFETY EQUIPMENT
Lab coat Detergents Sharps container
Hand wash sta-
tion
Fire ex-tinguisher
Autoclave Protective glasses
Eye wash station
Biosafety cabinet
0
20
40
60
80
100 9488 86
76
1815 14
11 11
Perc
ent o
f lab
orat
orie
s, %
![Page 54: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/54.jpg)
STAFF TRAINED IN KEY TESTS AND LABORATORY MANGEMENT SKILLS
Quality control
Inventory
Biosafety
AFB
HIV rapid test
Malaria
Hematology
Syphilis
Clinic chemistry
CD4 test
Man
agem
ent s
kills
HIV-
rela
ted
test
ing
0 10 20 30 40 50 60 70 80 90
54
43
35
84
79
77
67
67
65
60
Percent of staff, %
![Page 55: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/55.jpg)
QUALITY ASSURANCE/QUALITY CONTROL FOR HIV RELATED TESTS
HIV rapid test (n=635)
CD4 test (n=175)
Hematology (n=314)
Clinical chemistry test (n=171)
0
20
40
60
80
100100
66
48
70
37
24
14 13
39
47
1723
Internal controlInternal proficiencyExternal proficiency
Perc
ent o
f lab
orat
orie
s, %
![Page 56: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/56.jpg)
OUTLINE
• Rationale & Objectives• General findings• Capacity score• Summary& Implications
![Page 57: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/57.jpg)
ICAP’S LABORATORY CAPACITY BUILDING FRAMEWORK
Objective Components
1. Improve Integrated Laboratory Infrastructure
physical infrastructure, equipment and accessories
2. Strengthen laboratory personnel capacity
personnel capacity to provide high-quality diagnostic services
3. Improve Laboratory Quality Management System
quality management systems & lab accreditation
4. Strengthen the laboratory network system
laboratory referral system & EQA schemes
![Page 58: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/58.jpg)
LABORATORY CAPACITY SCOREScore Domain Lab PFaCTS Variables
1. Improve Integrated Laboratory Infrastructure
• HIV related tests• laboratory equipment• biosafety equipment/materials• supply chain management system • supply shortages• data collection & specimen
transportation
2. Strengthen laboratory personnel capacity
• % staff received training on each test
3. Improve Laboratory Quality Management System
• SOP, Internal controls, internal and external proficiency testing
Total Points = 100
![Page 59: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/59.jpg)
CAPACITY SCORES BY FACILITY TYPE AND LOCATION
All (n=654)
Primary (n=511)
Secondary (n=126)
Tertiary (n=17)
Urban (n=111)
Semi-urban (n=250)
Rural (n=240)
Unknown (n=53)
0
20
40
60
80
100
4845
61 5953
4945 44
Aver
age
capa
city
sco
re
![Page 60: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/60.jpg)
CAPACITY SCORES BY COUNTRY AND YEAR
All countries (n=331)
Cote d'Ivoire (n=3)
DR Congo (n=6)
Ethiopia (n=74)
Kenya (n=125)
Mozambique (n=26)
Tanzania (n=97)
0
20
40
60
80
100
46
63
36
43 45
37
525156 55 56
50
43
5120112013
Aver
age
capa
city
sco
re
*Restricted to laboratories completing both 2011 and 2013 Pfacts rounds.
![Page 61: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/61.jpg)
CAPACITY SCORES BY FACILITY AND LOCATION
*Restricted to laboratories completing both 2011 and 2013 PFaCTs rounds.
Primary (n=212)
Secondary (n=106)
Tertiary lab (n=13)
Urban (n=57)
Semi-urban
(n=113)
Rural (n=132)
Unknown (n=29)
0
20
40
60
80
100
41
5560
4552
4339
45
62 6156 56
4744 2011
2013
Aver
age
capa
city
sco
re
![Page 62: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/62.jpg)
OUTLINE
• Rationale & Objectives• General findings• Capacity score• Summary& Implications
![Page 63: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/63.jpg)
SUMMARY • ICAP supports a wide range of capacity
building activities in the countries where we work
• Technical support areas identified include QA/QC, human resources and infrastructure
• Capacity at ICAP laboratories
– highest at secondary and tertiary and urban facilities
– increased between 2011 and 2013
![Page 64: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/64.jpg)
IMPLICATIONS
• Laboratory PFaCTS can be used to identify and address technical support area needs
• Use of capacity scoring allows for a comprehensive approach to monitoring capacity from routinely collected PFaCTS data
![Page 65: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/65.jpg)
PFACTS DATA USE
• Analysis of key PFaCTS variables can identify areas for targeted technical assistance as well as achievement of program successes
• Innovative approaches in the use of PFaCTS data help us better understand the programs we support
![Page 66: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/66.jpg)
Where’s the Data?
![Page 67: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/67.jpg)
![Page 68: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/68.jpg)
URS
![Page 69: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/69.jpg)
![Page 70: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/70.jpg)
Wiki
![Page 71: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/71.jpg)
![Page 72: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/72.jpg)
Wiki
![Page 73: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/73.jpg)
Acknowledgements
• Country M&E, Laboratory and Clinical Teams
• Bereket Alemayehu, Yingfeng Wu, Suzue Saito, SI Specialists
![Page 74: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/74.jpg)
Thank You
![Page 75: I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson](https://reader035.vdocuments.site/reader035/viewer/2022070401/56649f1b5503460f94c30236/html5/thumbnails/75.jpg)
FOR MORE INFORMATION
PFaCTS resources
• To view the questionnaires and reports for all rounds, visit the ICAP Data Dissemination page and select PFaCTS.
• http://icapdatadissemination.wikischolars.columbia.edu/Welcome
• To access more PFaCTS results, log into the URS
• https://urs2.icap.columbia.edu/